Latest Breaking News On - Michael forsting - Page 1 : comparemela.com

Bayer initiates Phase III Studies with Investigational Contrast Agent Gadoquatrane

Comprehensive clinical development program called QUANTI includes two Phase III studies in adults and one pediatric study investigating gadoquatrane for use in MRI across all body regions and across ages from birth to adulthood

United statesMichael forstingKonstanze diefenbachNational institute of biomedical imagingGlobal head of radiology research developmentUniversity essenClarivate decision resources groupInterventional radiologyGlobal headRadiology researchNovel tetramericNational instituteBiomedical imagingMagnetic resonance imagingRetrieved juneArlington medical

Potentially safer MRI gadolinium-based contrast agent to enter testing | Scans used to diagnose, monitor MS

Potentially safer MRI gadolinium-based contrast agent to enter testing | Scans used to diagnose, monitor MS
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

United statesKonstanze diefenbachMichael forstingUniversity essenInterventional radiologyQuanti pediatricNorth america

Bayer initiates Phase III studies with investigational contrast agent gadoquatrane

WHIPPANY, N.J. (BUSINESS WIRE) Jun 27, 2023

United statesMichael forstingKonstanze diefenbachNational institute of biomedical imagingGlobal head of radiology research developmentUniversity essenClarivate decision resources groupInterventional radiologyGlobal headRadiology researchNovel tetramericBiomedical imagingMagnetic resonance imagingRetrieved juneImaging market guideStated edition

Bayer initiates Phase III studies with investigational contrast agent gadoquatrane

Bayer initiates Phase III studies with investigational contrast agent gadoquatrane
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKonstanze diefenbachMichael forstingClarivate decision resources groupUniversity essenNational institute of biomedical imagingGlobal head of radiology research developmentInterventional radiologyGlobal headRadiology researchNovel tetramericBiomedical imagingMagnetic resonance imagingRetrieved juneImaging market guideStated edition

Bayer initiates Phase III studies with investigational contrast agent gadoquatrane

WHIPPANY, N.J. (BUSINESS WIRE) Jun 27, 2023

United statesKonstanze diefenbachMichael forstingClarivate decision resources groupGlobal head of radiology research developmentNational institute of biomedical imagingUniversity essenInterventional radiologyGlobal headRadiology researchNovel tetramericBiomedical imagingMagnetic resonance imagingRetrieved juneImaging market guideStated edition